相关实验视频
Updated: Jun 11, 2025

Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
Published on: May 17, 2018
致死于COVID-19不会影响晚期癌症患者的息治疗持续时间:一项回顾性队列研究
Rafael Tavares Jomar1, Jéssica Thaís Nascimento Marques1, Livia Costa de Oliveira1
1Instituto Nacional de Câncer (INCA), Rio de Janeiro, RJ, Brazil.
COVID-19死亡人数并没有改变晚期癌症患者接受息治疗的时间. 这项研究发现,无论死亡原因如何,护理时间没有显著差异.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 传染性疾病 传染性疾病
背景情况:
- 以前的研究表明,COVID-19死亡不会影响晚期癌症患者的息治疗持续时间.
- 获得瘤缓解护理的机会往往与生命的结束相吻合.
- 这项研究的回顾性设计支持因果推理.
研究的目的:
- 为了确定COVID-19相关的死亡是否影响了晚期癌症患者的息治疗时间.
- 在瘤学中调查COVID-19对终身护理持续时间的影响.
主要方法:
- 一项追溯的队列研究,对1104名晚期癌症患者进行了追溯的队列研究,这些患者在专属息治疗下死亡.
- 统计分析包括威尔科克森等级和日志等级测试.
- 使用Kaplan-Meier估计器,根据死亡原因 (癌症与COVID-19) 进行比较生存曲线.
主要成果:
- 133名患者 (12.05%) 因COVID-19而死亡.
- 对于癌症和COVID-19死亡组,专属息治疗的中位持续时间不到一个月.
- 两组之间的息治疗持续时间没有统计学上显著的差异.
结论:
- 由于COVID-19导致的死亡并没有改变晚期癌症患者专属息治疗的持续时间.
- 这些发现表明,大流行对息护理持续时间的影响对于这个患者群体来说是最小的.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
相关概念视频
Continuing Care
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...